Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
P07858
UPID:
CATB_HUMAN
Alternative names:
APP secretase; Cathepsin B1
Alternative UPACC:
P07858; B3KQR5; B3KRR5; Q503A6; Q96D87
Background:
Cathepsin B, also known as APP secretase or Cathepsin B1, is a thiol protease involved in the intracellular degradation and turnover of proteins. It plays a crucial role in the solubilization of cross-linked thyroglobulin in the thyroid follicle lumen and has been implicated in tumor invasion and metastasis.
Therapeutic significance:
Cathepsin B's abnormal expression is linked to Keratolytic winter erythema, a genodermatosis with high penetrance and variable expressivity. Understanding the role of Cathepsin B could open doors to potential therapeutic strategies for this condition and its associated symptoms.